bosutinib Articles
FDA nod for Pfizer's rare leukemia drug Bosulif
6 September 2012
FDA OKs Pfizer’s Inlyta and accepts NDA for bosutinib
30 January 2012
Two Pfizer cancer drug candidates, crizotinib and bosutinib, accepted for filing in Europe
18 August 2011
Pfizer commences rolling FDA submission for lung cancer drug crizotinib; denies German VAT evasion
17 January 2011
ASH meeting: Pfizer’s bosutinib disappoints in myeloid leukemia trial; Novartis’ Tasigna beats Glivec in CML study
7 December 2010
Showing 1-5 of 5 articles
- 1
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
